Dollars may not buy as many QALYs as we think: A problem with defining quality-of-life adjustments

Medical Decision Making

Volumn 17, Issue 3, 1997, Pages 276-284

  Fryback, Dennis G ^a,d   Lawrence Jr , William F ^b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Cost effectiveness methodology; Cost utility analysis; QALY; Quality adjusted life years; Quality of life assessment; Utility

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST UTILITY ANALYSIS; HEALTH STATUS; QUALITY OF LIFE; RATING SCALE;

ADULT; AGED; COMORBIDITY; COST-BENEFIT ANALYSIS; DECISION MAKING, COMPUTER-ASSISTED; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH CARE RATIONING; HUMANS; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; SURVIVAL ANALYSIS;

EID: 0030923733     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9701700303     Document Type: Article

References (25)

1. Goldman L, Gordon DJ, Rifkind BM, et al. Cost and health implications of cholesterol lowering. Circulation. 1992;85: 1960-8.
2. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-71.
3. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13:89-102.
4. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716-21.
5. Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychology. 1982;1:61-80.
6. Drummond MF, Stoddart GL. Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford, U.K.: Oxford Medical Publications, 1987.
7. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis. 1978;31:697-704.
8. Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes: comparison of assessment methods. Med Decis Making. 1984;4:315-29.
9. Patrick DL, Erickson P. Health Status and Health Policy. Allocating Resources to Health Care. New York: Oxford University Press, 1993.
10. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1-30.
11. Pliskin JS, Sheppard DS, Weinstein MC. Utility functions for life years and health states. Operations Research. 1980;28: 206-24.
12. Wong JB, Sonnenberg FA, Salem DN, Pauker SG. Myocardial revascularization for chronic stable angina: analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med. 1990;113: 852-71.
13. Hogenhuis W, Stevens SK, Wang P, et al. Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome. Circulation. 1993;88 [part 2]:437-446.
14. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA. 1993;269:2650-8.
15. Desch CE, Hillner BE, Smith TJ, Retchin SM. Should elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life- expectancy outcomes. J Clin Oncol. 1993;11:777-82.
16. Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients: decision and cost-effectiveness analyses. JAMA. 1995;273:712-20.
17. Freedberg KA, Tosteson ANA, Cotton DJ, Goldman L. Optimal management strategies for HIV-infected patients who present with cough or dyspnea. J Gen Intern Med. 1992;7:261-72.
18. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer: a decision analytic view. JAMA. 1994;272:773-80.
19. Tousignant P, Cosio MG, Levy RD, Groome PA. Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep. 1994;17:52-60.
20. Mark DB, Hlatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogcn activator as compared with streptokinase for acute myocardial infarction. N Engl J Med. 1995;332:1418-24.
21. Kamlet MS, Paul N, Greenhouse J, Kupfer D, Frank E, Wade M. Cost utility analysis of maintenance treatment for recurrent depression. Controlled Clin Trials. 1995;16:17-40.
22. Gold MR, Franks P, McCoy K. Condition weights for chronic diseases from a nationally representative sample (abstr). Med Decis Making. 1994;14:431.
23. Erickson P, Wilson R, Shannon I. Years of health life. In: Healthy People 2000: Statistical Notes, Number 7, April 1995. Centers for Disease Control and Prevention/National Center for Health Statistics, Bethesda, MD.
24. Berthelot J-M, Roberge R, Wolfson MC. The calculation of health-adjusted life expectancy for a Canadian province using a multi-attribute utility function: a first attempt. Proceedings of the Sixth Meeting of the International Network on Health Expectancy (REVES-6), Montpellier, France, October 7-12, 1992.
25. Bosch JL. Floating anchors and the fountain of youth. SMDM Newsletter, March 1995;6(1):6. Society for Medical Decision Making, George Washington University Office of CME, 2300 K Street NW, Washington, DC 20037.